Search Results

Sanford Burnham Prebys announced plans to recruit up to 20 new faculty positions in research areas including cancer, neurodegeneration and computational biology.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Cancers from a team of cancer researchers primarily at the NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute and Scripps MD Anderson in La Jolla, California.

Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California San Diego School of Medicine received a $9-million grant from the National Institute on Drug Abuse at the National Institutes of Health.

Viscient Biosciences announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a liver fibrosis phenotype in a 3D human tissue model of MASH demonstrating strong comparability to the native disease by multiple measures.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd., a global specialty pharmaceutical company based in Japan, announced that its board of directors has approved plans to invest up to $530 million to build a new, state-of-the-art manufacturing facility in Sanford, North Carolina.

Rapid Technologies, a Premier ServiceNow partner, recently completed a ServiceNow modernization project for San Diego-based Sanford Burnham Prebys Medical Discovery Institute.

Cerecor Inc. today announced that it has entered into an exclusive license agreement with Sanford Burnham Prebys for the worldwide development and commercialization of an immune checkpoint program.

Soft Bones, Inc., an organization dedicated to providing information, education and support to those affected by hypophosphatasia (HPP), is pleased to award its annual Maher Family Grant to Flávia Amadeu de Oliveira, PhD, a post-doctoral associate at the Millan Lab at Sanford Burnham Prebys Medical Discovery Institute in La Jolla, California, to study the potential of gene therapy in HPP.